Page last updated: 2024-10-24

regulation of neutrophil extravasation

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate or extent of neutrophil extravasation. [GOC:mah]

Neutrophil extravasation, the process by which neutrophils exit the bloodstream and migrate to sites of inflammation, is a tightly regulated cascade of events involving adhesion molecules, chemoattractants, and signaling pathways. It can be summarized in four main steps:

1. **Rolling:** Neutrophils initially interact with the vascular endothelium through weak, transient interactions with selectin molecules, such as E-selectin and P-selectin. This interaction allows neutrophils to slow down and "roll" along the endothelium.

2. **Activation and Tight Adhesion:** As neutrophils encounter chemokines, such as IL-8 and CXCL1, they become activated and express integrins like LFA-1 and Mac-1. These integrins bind to their ligands, ICAM-1 and ICAM-2, on the endothelium, leading to firm adhesion of neutrophils to the vascular wall.

3. **Diapedesis:** Adhered neutrophils then migrate through the endothelial junctions, a process known as diapedesis. This involves complex interactions between the neutrophil cytoskeleton, adhesion molecules, and the endothelial cell junctions.

4. **Migration:** Once in the tissue, neutrophils follow chemoattractant gradients, such as those created by bacterial products or chemokines, to reach the site of inflammation. This movement involves the coordinated action of the neutrophil cytoskeleton and signaling pathways.

The regulation of neutrophil extravasation is essential for controlling inflammation. Dysregulation of this process can contribute to both excessive and insufficient inflammatory responses, leading to various pathological conditions. For example, impaired neutrophil extravasation can result in increased susceptibility to infections, while excessive extravasation can lead to tissue damage in conditions like sepsis or autoimmune diseases.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Alpha-(1,3)-fucosyltransferase 7An alpha-(1,3)-fucosyltransferase 7 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q11130]Homo sapiens (human)

Compounds (11)

CompoundDefinitionClassesRoles
2,3-dihydroxybenzoic acid2,3-dihydroxybenzoic acid : A dihydroxybenzoic acid that is benzoic acid substituted by hydroxy groups at positions 2 and 3. It occurs naturally in Phyllanthus acidus and in the aquatic fern Salvinia molesta.

2,3-dihydroxybenzoic acid: RN given refers to parent cpd

dihydroxybenzoic acid : Any member of the class of hydroxybenzoic acids carrying two phenolic hydroxy groups on the benzene ring and its derivatives.
dihydroxybenzoic acidhuman xenobiotic metabolite;
plant metabolite
protocatechuic acid3,4-dihydroxybenzoic acid : A dihydroxybenzoic acid in which the hydroxy groups are located at positions 3 and 4.

protocatechuic acid: RN given refers to parent cpd; structure
catechols;
dihydroxybenzoic acid
antineoplastic agent;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor;
human xenobiotic metabolite;
plant metabolite
gallic acidgallate : A trihydroxybenzoate that is the conjugate base of gallic acid.trihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite
beta-resorcylic acidbeta-resorcylic acid: RN given refers to parent cpd; structure
2,5-dihydroxybenzoic acid2,5-dihydroxybenzoic acid : A dihydroxybenzoic acid having the two hydroxy groups at the 2- and 5-positions.

2,5-dihydroxybenzoic acid: RN given refers to parent cpd; a oxidative product of saligenin
dihydroxybenzoic acidEC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
fungal metabolite;
human metabolite;
MALDI matrix material;
mouse metabolite
veratric acid3,4-dimethoxybenzoic acid : A member of the class of benzoic acids that is benzoic acid substituted by methoxy groups at positions 2 and 3.

veratric acid: RN given refers to parent cpd; structure
benzoic acidsallergen;
plant metabolite
methyl gallatemethyl 3,4,5-trihydroxybenzoate : A gallate ester obtained by the formal condensation of gallic acid with methanol. It exhibits anti-oxidant, anti-tumor, anti-microbial and anti-inflammatory properties.

methyl gallate: has both immunosuppressive and phytogenic antineoplastic activities; isolated from Acer saccharinum
gallate esteranti-inflammatory agent;
antioxidant;
plant metabolite
3,4,5-trimethoxybenzoic acid3,4,5-trimethoxybenzoic acid : A benzoic acid derivative carrying 3-, 4- and 5-methoxy substituents.

3,4,5-trimethoxybenzoic acid: RN given refers to parent cpd; structure
benzoic acids;
methoxybenzenes
human urinary metabolite;
human xenobiotic metabolite;
plant metabolite
syringic acidsyringic acid : A dimethoxybenzene that is 3,5-dimethyl ether derivative of gallic acid.

syringic acid: RN given refers to parent cpd; structure in third source
benzoic acids;
dimethoxybenzene;
phenols
plant metabolite
epigallocatechin gallate(-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin.

epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis)
flavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
guanosine diphosphateGuanosine Diphosphate: A guanine nucleotide containing two phosphate groups esterified to the sugar moiety.guanosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate
Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor